China Paves Way for Faster Approval of Foreign-Made Drugs

Pharmaceutical companies will soon be able to apply for approval for some new medicines simultaneously inside and outside of China, according to new regulations issued by the country’s drug authority.

China’s State Drug Administration on Tuesday published the first detailed guidelines for accepting clinical trial data obtained outside of the country, a major step toward removing the time lag that forces patients in China to wait years before they can use new drugs approved overseas.


You’ve accessed an article available only to subscribers

Try 4 weeks for $0.99



Source link

Leave a Reply

Your email address will not be published.